We are independent & ad-supported. We may earn a commission for purchases made through our links.
Advertiser Disclosure
Our website is an independent, advertising-supported platform. We provide our content free of charge to our readers, and to keep it that way, we rely on revenue generated through advertisements and affiliate partnerships. This means that when you click on certain links on our site and make a purchase, we may earn a commission. Learn more.
How We Make Money
We sustain our operations through affiliate commissions and advertising. If you click on an affiliate link and make a purchase, we may receive a commission from the merchant at no additional cost to you. We also display advertisements on our website, which help generate revenue to support our work and keep our content free for readers. Our editorial team operates independently of our advertising and affiliate partnerships to ensure that our content remains unbiased and focused on providing you with the best information and recommendations based on thorough research and honest evaluations. To remain transparent, we’ve provided a list of our current affiliate partners here.

What is Antithrombin III Deficiency?

By D. Jeffress
Updated Mar 03, 2024
Our promise to you
The Health Board is dedicated to creating trustworthy, high-quality content that always prioritizes transparency, integrity, and inclusivity above all else. Our ensure that our content creation and review process includes rigorous fact-checking, evidence-based, and continual updates to ensure accuracy and reliability.

Our Promise to you

Founded in 2002, our company has been a trusted resource for readers seeking informative and engaging content. Our dedication to quality remains unwavering—and will never change. We follow a strict editorial policy, ensuring that our content is authored by highly qualified professionals and edited by subject matter experts. This guarantees that everything we publish is objective, accurate, and trustworthy.

Over the years, we've refined our approach to cover a wide range of topics, providing readers with reliable and practical advice to enhance their knowledge and skills. That's why millions of readers turn to us each year. Join us in celebrating the joy of learning, guided by standards you can trust.

Editorial Standards

At The Health Board, we are committed to creating content that you can trust. Our editorial process is designed to ensure that every piece of content we publish is accurate, reliable, and informative.

Our team of experienced writers and editors follows a strict set of guidelines to ensure the highest quality content. We conduct thorough research, fact-check all information, and rely on credible sources to back up our claims. Our content is reviewed by subject-matter experts to ensure accuracy and clarity.

We believe in transparency and maintain editorial independence from our advertisers. Our team does not receive direct compensation from advertisers, allowing us to create unbiased content that prioritizes your interests.

Antithrombin III deficiency is a rare disease that predisposes individuals to developing potentially serious blood clots. A genetic mutation impairs the body's ability to make functional antithrombin III enzymes, which play a vital role in preventing coagulation. Without treatment, a severe deficiency may lead to life-threatening clots in the lungs, heart, or elsewhere in the body. Most cases of antithrombin III deficiency can be effectively managed with daily doses of blood-thinning medications.

There is normally a careful balance of enzymes in the bloodstream; enzymes such as thrombin and factor X prevent the blood from becoming too thin, and chemicals such as antithrombin III and heparin prevent the blood from thickening. In the case of an antithrombin III deficiency, coagulating enzymes prosper and the risk of clotting is high.

There are two main types of antithrombin III deficiency, both of which are inherited in an autosomal dominant pattern. In type one, a genetic mutation impairs the body's ability to produce new antithrombin. In type two, there are approximately normal levels of the enzyme, but they fail to function properly.

Many people who inherit antithrombin III deficiency never experience clotting disorders or other health problems. Symptoms are most likely to arise around the age of 30, though it is possible to experience clots much earlier or later in life. The risk of developing clots is increased in people who smoke or suffer from high blood pressure, high cholesterol, and obesity.

A blood clot can cause a variety of symptoms depending on its site and size. Deep vein thrombosis in one of the legs is the most common place for a clot in people with the disorder, and may cause leg swelling and throbbing pain. Additional symptoms may include shortness of breath, dizziness, a bloody cough, and full-body weakness.

Most cases of antithrombin III deficiency are diagnosed before patients experience dangerous clots. Routine blood tests for other conditions might reveal unusually low levels of antithrombin and increased activity of coagulating enzymes. Genetic testing can confirm that a patient does indeed carry a specific genetic mutation. Imaging tests such as ultrasounds and echocardiographs are usually performed to screen for existing clots and check for possible damage in the heart, liver, kidneys, and other organs.

People who have antithrombin III deficiencies but do not develop symptoms may not need treatment. Instead, doctors generally recommend that they attend regular health checkups to ensure that problems do not arise. If clotting does occur, patients are started on a daily regimen of anticoagulant drugs, such as warfarin, heparin, or synthetic antithrombin. Surgery may be needed to break up a large blood clot in an emergency situation.

The Health Board is dedicated to providing accurate and trustworthy information. We carefully select reputable sources and employ a rigorous fact-checking process to maintain the highest standards. To learn more about our commitment to accuracy, read our editorial process.
Discussion Comments
The Health Board, in your inbox

Our latest articles, guides, and more, delivered daily.

The Health Board, in your inbox

Our latest articles, guides, and more, delivered daily.